Anaesthesia | Patient specific populations | Management of neurological and neuromuscular diseases: GBS, MG, MND, CIPN, CIPM, Parkinson's

Management of Neurological and Neuromuscular Diseases: GBS, MG, MND, CIPN, CIPM, Parkinson's
Session Overview
Description
This session describes the management of patients admitted to critical care with Guillain-Barré Syndrome, motor neurone disease, myasthenia gravis, critical illness polyneuropathy, critical illness neuromyopathy and Parkinson's disease.

Learning Objectives
By the end of this session you will be able to:

• Define GBS, MG, MND, CIPN, CIPM and Parkinson's
• List the clinical features of GBS, MG, MND, CIPN, CIPM and Parkinson's
• Describe the indications for critical care admission for GBS, MG, MND, CIPN, CIPM and Parkinson's
• Describe critical care management for GBS, MG, MND, CIPN, CIPM and Parkinson's

Prerequisites

• Before commencing this session you should complete:
• Action Potential, NMJ and Skeletal Muscle Contraction (001-0629)
• Autonomic Nervous System (001-0676)
• The Neuromuscular Junction & the Nicotinic Acetylcholine Receptor (001-0779)

Early critical care involvement can have a significant improvement in outcome for patients with acute neurological and neuromuscular conditions.

However, these patients can remain dependent on critical care support for a prolonged period of time. This can result in significant demands on the patient, as well as on nursing, medical and other healthcare professionals involved.

Knowledge of a range neurological and neuromuscular conditions is essential for critical care clinicians.